Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020108194 - USE OF PROSTAGLANDIN E1 METHYL ESTER IN PREPARING VASODILATOR DRUG

Publication Number WO/2020/108194
Publication Date 04.06.2020
International Application No. PCT/CN2019/113558
International Filing Date 28.10.2019
IPC
A61K 31/5575 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
557Eicosanoids, e.g. leukotrienes
5575having a cyclopentane ring, e.g. prostaglandin E2, prostaglandin F2-alpha
A61P 9/08 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
08Vasodilators for multiple indications
A61P 9/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
A61P 9/10 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
10for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
A61P 9/04 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
A61P 7/02 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
7Drugs for disorders of the blood or the extracellular fluid
02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
CPC
A61K 31/5575
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
557Eicosanoids, e.g. leukotrienes ; or prostaglandins
5575having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
A61P 17/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
17Drugs for dermatological disorders
A61P 17/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
17Drugs for dermatological disorders
10Anti-acne agents
A61P 3/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
08for glucose homeostasis
10for hyperglycaemia, e.g. antidiabetics
A61P 7/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
7Drugs for disorders of the blood or the extracellular fluid
02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
A61P 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
Applicants
  • 西安力邦肇新生物科技有限公司 XI' AN LIBANG ZHAOXIN BIOTECHNOLOGY CO., LTD. [CN]/[CN]
Inventors
  • 王汝涛 WANG, Rutao
  • 安龙 AN, Long
  • 赵熠 ZHAO, Yi
  • 庞菁华 PANG, Jinghua
  • 陈涛 CHEN, Tao
Agents
  • 北京三友知识产权代理有限公司 BEIJING SANYOU INTELLECTUAL PROPERTY AGENCY LTD.
Priority Data
201811423944.427.11.2018CN
Publication Language Chinese (ZH)
Filing Language Chinese (ZH)
Designated States
Title
(EN) USE OF PROSTAGLANDIN E1 METHYL ESTER IN PREPARING VASODILATOR DRUG
(FR) UTILISATION DE MÉTHYL ESTER DE PROSTAGLANDINE E1 DANS LA PRÉPARATION D’UN MÉDICAMENT VASODILATATEUR
(ZH) 前列腺素E1甲酯在制备扩张血管药物中的应用
Abstract
(EN)
Provided in the present invention is a use of prostaglandin E1 methyl ester in preparing a vasodilator drug. The structural formula of the prostaglandin E1 methyl ester is represented by formula (1). The vasodilator drug is a drug used to treat the following diseases: a microcirculatory disorder, coronary heart disease, angina, heart failure, pulmonary heart disease, cerebral infarction, amniotic fluid embolism, or scleroderma.
(FR)
La présente invention concerne une utilisation de méthyl ester de prostaglandine E1 dans la préparation d’un médicament vasodilatateur. La formule structurale du méthyl ester de prostaglandine E1 est représentée par la formule (1). Le médicament vasodilatateur est un médicament utilisé pour traiter les maladies suivantes : un trouble microcirculatoire, une maladie cardiaque coronaire, l’angine, l’insuffisance cardiaque, une maladie cardiaque pulmonaire, un infarctus cérébral, un embolisme du liquide amniotique ou une sclérodermie.
(ZH)
本发明提供了前列腺素E1甲酯在制备扩张血管药物中的应用。所述前列腺素E1甲酯结构如式(I)所示;所述扩张血管药物是用于治疗如下疾病的药物:微循环障碍、冠心病、心绞痛、心力衰竭、肺心病、脑梗死、羊水栓塞、或硬皮病。
Also published as
Latest bibliographic data on file with the International Bureau